tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lexeo appoints Jose Manuel Otero as COO
PremiumThe FlyLexeo appoints Jose Manuel Otero as COO
2M ago
Lexeo Therapeutics price target lowered to $10 from $13 at H.C. Wainwright
Premium
The Fly
Lexeo Therapeutics price target lowered to $10 from $13 at H.C. Wainwright
2M ago
Lexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
Premium
Company Announcements
Lexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
2M ago
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & IdeasRaymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
3M ago
Lexeo Therapeutics initiated with a Strong Buy at Raymond James
Premium
The Fly
Lexeo Therapeutics initiated with a Strong Buy at Raymond James
3M ago
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
Premium
The Fly
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
3M ago
Lexeo Therapeutics files to sell 1.25M shares of common stock for holders
PremiumThe FlyLexeo Therapeutics files to sell 1.25M shares of common stock for holders
4M ago
Lexeo Therapeutics reports Q3 EPS (33c), consensus (44c)
Premium
The Fly
Lexeo Therapeutics reports Q3 EPS (33c), consensus (44c)
4M ago
Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright
Premium
The Fly
Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100